Creo Medical Group PLC
LSE:CREO

Watchlist Manager
Creo Medical Group PLC Logo
Creo Medical Group PLC
LSE:CREO
Watchlist
Price: 16.625 GBX 3.1% Market Closed
Market Cap: 68.5m GBX
Have any thoughts about
Creo Medical Group PLC?
Write Note

Wall Street
Price Targets

CREO Price Targets Summary
Creo Medical Group PLC

Wall Street analysts forecast CREO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CREO is 58.65 GBX with a low forecast of 45.45 GBX and a high forecast of 73.5 GBX.

Lowest
Price Target
45.45 GBX
173% Upside
Average
Price Target
58.65 GBX
253% Upside
Highest
Price Target
73.5 GBX
342% Upside
Creo Medical Group PLC Competitors:
Price Targets
METN
Metall Zug AG
61% Upside
002223
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
35% Upside
002901
Double Medical Technology Inc
53% Upside
2216
Broncus Holding Corp
137% Upside
CYC
Cyclopharm Ltd
100% Upside
PRM
Prim SA
71% Upside
MYO
Myomo Inc
47% Upside
IPD
ImpediMed Ltd
169% Upside

Revenue
Forecast

Revenue Estimate
Creo Medical Group PLC

The compound annual growth rate of Creo Medical Group PLC's revenue for the next 3 years is -3%.

N/A
Past Growth
-3%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Creo Medical Group PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
9%
Average Beat

Net Income
Forecast

Net Income Estimate
Creo Medical Group PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-55%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CREO's stock price target?
Price Target
58.65 GBX

According to Wall Street analysts, the average 1-year price target for CREO is 58.65 GBX with a low forecast of 45.45 GBX and a high forecast of 73.5 GBX.

What is Creo Medical Group PLC's Revenue forecast?
Projected CAGR
-3%

The compound annual growth rate of Creo Medical Group PLC's revenue for the next 3 years is -3%.

Back to Top